Benjamin Looker's Net Worth

$356 Thousand

Estimate Recalculated Nov 1, 2024 04:52AM EST

Who is Benjamin Looker?

Benjamin Looker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Esperion Therapeutics, Inc., and Trillium Therapeutics Inc..

SEC CIK

Benjamin Looker's CIK is 0001859509

Past Insider Trading and Trends

2022 was Benjamin Looker's most active year for acquiring shares with 3 total transactions. Benjamin Looker's most active month to acquire stocks was the month of February. 2023 was Benjamin Looker's most active year for disposing of shares, totalling 2 transactions. Benjamin Looker's most active month to dispose stocks was the month of December. 2021 saw Benjamin Looker paying a total of $0.00 for 190,000 shares, this is the most they've acquired in one year. In 2023 Benjamin Looker cashed out on 7,637 shares for a total of $46,044.49, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+119.53%
100K
—
—
183.66K
Mar 14
Form 4
-1.52%
-1.29K
$1.27
-$1,640.88
83.66K
Apr 19
Form 4
+31.81%
20.5K
—
—
84.95K
Mar 14
Form 4
-8.96%
-6.35K
$7.00
-$44,403.61
64.45K
Jan 18
Form 4
—
0
—
—
0
Jun 7
Form 4
∞
70.8K
—
—
70.8K
Jan 27
Form 3
—
0
—
—
0
No matching records found

Trillium Therapeutics Inc. No price found

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 17
Form 4
—
0
—
—
0
May 3
Form 3
—
0
—
—
0
No matching records found